Beyond viral recognition: Opportunities and challenges for DNA aptamers targeting tick-borne encephalitis virus
Tick-borne encephalitis virus (TBEV), which can potentially cause severe neurological disease, remains an important public health concern across both Europe and Asia.1,2,3 Prophylactic vaccines are available; however, effective, widely accepted antiviral treatments remain lacking.1,2 As shown in this issue of Molecular Therapy Nucleic Acids, to address this gap, Fujii et al.4 identified single-stranded DNA (ssDNA) aptamers that recognize the TBEV envelope (E) protein and bind viral and subviral particles.
Authors
- Masayasu Kuwahara (ORCID: https://orcid.org/0000-0002-0810-4627)
Institutions
- Nihon University (JP)
Publication Details
- Journal
- Molecular Therapy — Nucleic Acids
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1016/j.omtn.2026.103169
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science